Literature DB >> 30826773

Calculated plasma volume status and outcomes in patients undergoing coronary bypass graft surgery.

Annette Marie Maznyczka1,2,3, Mohamad Fahed Barakat1,4, Bassey Ussen1, Amit Kaura1, Huda Abu-Own1, Fadi Jouhra1, Hannah Jaumdally5, George Amin-Youssef1, Niki Nicou6, Max Baghai6, Ranjit Deshpande6, Olaf Wendler6, Shyam Kolvekar7, Darlington O Okonko1,4.   

Abstract

OBJECTIVES: Congestion is associated with worse outcomes in critically ill surgical patients but can be difficult to quantify noninvasively. We hypothesised that plasma volume status (PVS), estimated preoperatively using a validated formula that enumerates percentage change from ideal plasma volume (PV), would provide incremental prognostic utility after coronary artery bypass graft (CABG) surgery.
METHODS: In this retrospective cohort study, patients who underwent CABG surgery (1999-2010) were identified from a prospectively collected database. Actual ([1-haematocrit] x [a+(b x weight [kg])]) and ideal (c x weight [kg]) PV were obtained from equations where a, b and c are sex-dependent constants. Calculated PVS was then derived (100% x [(actual-ideal)/ideal]).
RESULTS: In 1887 patients (mean age 67±10 years; 79% male; median European System for Cardiac Operative Risk Evaluation [EuroSCORE] 4), mean PVS was -8.2±9%. While 8% of subjects had clinical evidence of congestion, a relatively increased PV (PVS >0%) was estimated in 17% and correlated with lower serum sodium, higher EuroSCORE and a diagnosis of diabetes mellitus. A PVS≥5.6% was optimally prognostic and associated with greater mortality (HR: 2.31, p=0.009), independently of, and incremental to, EuroSCORE, New York Heart Association class and serum sodium. A PVS≥5.6% also independently predicted longer intensive care (β: 0.65, p=0.007) and hospital (β: 2.01, p=0.006) stays, and greater postoperative renal (OR: 1.61, p=0.008) and arrhythmic (OR: 1.29, p=0.03) complications.
CONCLUSIONS: Higher PVS values, calculated simply from weight and haematocrit, are associated with worse inpatient outcomes after CABG. PVS could help refine risk stratification and further investigations are warranted to evaluate the potential clinical utility of PVS-guided management in patients undergoing CABG. © Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  coronary artery disease surgery; heart failure

Mesh:

Year:  2019        PMID: 30826773     DOI: 10.1136/heartjnl-2018-314246

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  8 in total

1.  Predictive value of overt and non-overt volume overload in patients with high- or low-gradient aortic stenosis undergoing transcatheter aortic valve implantation.

Authors:  Ulrich Fischer-Rasokat; Matthias Renker; Christoph Liebetrau; Maren Weferling; Andreas Rieth; Andreas Rolf; Yeong-Hoon Choi; Christian W Hamm; Won-Keun Kim
Journal:  Cardiovasc Diagn Ther       Date:  2021-10

Review 2.  Estimated plasma volume status in heart failure: clinical implications and future directions.

Authors:  Masatake Kobayashi; Nicolas Girerd; Kevin Duarte; Tahar Chouihed; Taishiro Chikamori; Bertram Pitt; Faiez Zannad; Patrick Rossignol
Journal:  Clin Res Cardiol       Date:  2021-01-06       Impact factor: 5.460

3.  Calculated plasma volume status and outcomes in patients undergoing transcatheter aortic valve replacement.

Authors:  Tetsuro Shimura; Masanori Yamamoto; Ryo Yamaguchi; Yuya Adachi; Mitsuru Sago; Tatsuya Tsunaki; Ai Kagase; Yutaka Koyama; Toshiaki Otsuka; Fumiaki Yashima; Norio Tada; Toru Naganuma; Masahiro Yamawaki; Futoshi Yamanaka; Shinichi Shirai; Kazuki Mizutani; Minoru Tabata; Hiroshi Ueno; Kensuke Takagi; Yusuke Watanabe; Kentaro Hayashida
Journal:  ESC Heart Fail       Date:  2021-03-05

4.  The impact of subclinical congestion on the outcome of patients undergoing transcatheter aortic valve implantation.

Authors:  Christopher Adlbrecht; Felix Piringer; Jon Resar; Victoria Watzal; Martin Andreas; Andreas Strouhal; Waseem Hasan; Daniela Geisler; Gabriel Weiss; Martin Grabenwöger; Georg Delle-Karth; Markus Mach
Journal:  Eur J Clin Invest       Date:  2020-04-22       Impact factor: 4.686

5.  Clinical impact of estimated plasma volume status and its additive effect with the GRACE risk score on in-hospital and long-term mortality for acute myocardial infarction.

Authors:  Tsutomu Kawai; Daisaku Nakatani; Takahisa Yamada; Yasuhiko Sakata; Shungo Hikoso; Hiroya Mizuno; Shinichiro Suna; Tetsuhisa Kitamura; Katsuki Okada; Tomoharu Dohi; Takayuki Kojima; Bolrathanak Oeun; Akihiro Sunaga; Hirota Kida; Hiroshi Sato; Masatsugu Hori; Issei Komuro; Shunsuke Tamaki; Takashi Morita; Masatake Fukunami; Yasushi Sakata
Journal:  Int J Cardiol Heart Vasc       Date:  2021-03-11

6.  Predictive value of plasma volume status for contrast-induced nephropathy in patients with heart failure undergoing PCI.

Authors:  Chen He; Sicheng Zhang; Haoming He; Zhebin You; Xueqin Lin; Liwei Zhang; Jiankang Chen; Kaiyang Lin
Journal:  ESC Heart Fail       Date:  2021-10-26

7.  Estimated plasma volume status (ePVS) is a predictor for acute myocardial infarction in-hospital mortality: analysis based on MIMIC-III database.

Authors:  Jun Chen; Jiayi Shen; Dongsheng Cai; Tiemin Wei; Renyi Qian; Chunlai Zeng; Lingchun Lyu
Journal:  BMC Cardiovasc Disord       Date:  2021-11-08       Impact factor: 2.298

8.  Deviations From the Ideal Plasma Volume and Isolated Tricuspid Valve Surgery-Paving the Way for New Risk Stratification Parameters.

Authors:  Ena Hasimbegovic; Marco Russo; Martin Andreas; Paul Werner; Iuliana Coti; Dominik Wiedemann; Alfred Kocher; Günther Laufer; Benedikt S Hofer; Markus Mach
Journal:  Front Cardiovasc Med       Date:  2022-03-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.